Supporting the development and evaluation of neurosurgical technologies
Varaidzo (Vee) Mapunde
Co-Director at NIHR HealthTech Research Centre in Accelerated Surgical Care
We are pleased to announce our new clinical theme - neurosurgery, led by Mr Ryan Mathew, Associate Professor at the University of Leeds and an Honorary Consultant Neurosurgeon at Leeds Teaching Hospitals.
The aims of the neurosurgery theme are to evaluate and define the role of innovative and disruptive technologies on common pathologies within neurosurgery where there is potential impact for improving patient outcomes.
Indications of interest are brain tumours and degenerative spinal conditions. Technologies that are considered to have potential will be supported to progress to mixed methodology clinical trial evaluations, encompassing pilot, feasibility, and implementation. There will also be a focus on utilising technology in the context of advancing neurosurgical training and competence to enhance the quality of service provision.
Cross-cutting technologies of interest
Immersive Technologies
Immersive technologies (virtual and augmented reality) have been shown to engage people in their health and wellbeing. Neurosurgery has a long track record of being at the cutting edge of technology (examples include frameless stereotactic navigation, intra-op ultrasounds and MRI, robotics, real-time neurophysiology). It is therefore well placed to integrate and implement immersive technology into the peri-operative patient journey and neurosurgical training. The focus will be on patient education of complex neurosurgical concepts, pre- and intra-op navigation and surgical planning tools, post-op neuro-rehabilitation, and enhanced neurosurgical training using virtual and mixed reality environments to complement cadaveric and simulation teaching.
We are interested in:
领英推荐
Bespoke Patient Care
Brain tumours have clear individual and societal impacts (shortened life expectancy, loss of working years, loss of independence, decreased QoL). Each patient with a brain tumour is unique due to the nature of the disease on such an eloquent host organ. This inherent patient heterogeneity (coupled with intra-tumoural heterogeneity) means that a bespoke patient-facing approach is needed.
We are interested in:
Enhanced Detection of Neurosurgical Pathologies
Common neurosurgical pathologies such as brain tumours and chronic degenerative conditions benefit from enhanced imaging and detection, facilitating earlier diagnosis and better-informed management. In the case of infiltrating brain tumours, the ability to differentiate normal from diseased tissue in real-time can inform extent of resection and stop/go decisions intra-operatively. Real-time histology could also maximise the yield of diagnostic tissue and minimise the risk of a repeat procedure. Machine-learning algorithms can longitudinally detect brain tumour progression and inform prognosis and decision making for timing of intervention. Enhanced imaging of cervical degenerative pathology can inform choice of surgical procedure.
We are interested in:
What can you do if you would like to get involved:
Investment Champion Northern Powerhouse | Mentor | Paving the way for the future of radiological cancer diagnostics utilising innovative AI solutions
3 年Fantastic news!